USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Sinclair Pharmaceuticals Ltd

USPTO PatentsView assignee record - 6 granted patents across 9 technology areas, active 2015–2020. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61B (DIAGNOSIS; SURGERY; IDENTIFICATION).

Compiled byPlainPatent Editorial, US Patent Intelligence Editorial Team · May 15, 2026

Explore the portfolio See the ranking

Total patents granted

CPC technology areas

21.5

Avg claims per patent

-80%

5-year filing velocity

The verdict

Sinclair holds 6 US patents across 9 technology areas, rank #42,898 of 50,000 tracked assignees.

#42,898
of 50,000 US assignees by volume: Top 66%
by Innovation Score (30.2/100): 21.5
avg claims per patent: -80%
filing velocity, last 5 yrs

Portfolio overview

Sinclair Pharmaceuticals Ltd has been granted 6 US utility patents between 2015 and 2020, placing Sinclair Pharmaceuticals Ltd at rank #42,898 across all assignees tracked by PlainPatent. This portfolio spans 9 distinct Cooperative Patent Classification (CPC) subclasses, averaging 21.5 claims per patent with primary concentration in A61B (DIAGNOSIS; SURGERY; IDENTIFICATION). As a Foreign Corporation, Sinclair Pharmaceuticals Ltd is one of the more focused assignees in the PatentsView dataset. By volume, Sinclair sits between Silverback Therapeutics, Inc. (6 patents, rank #42,894) and Singapore Volition PTE. Limited (6 patents, rank #42,902) - the closest US assignees by grant volume. The composite Innovation Score of 30.2/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Between 2020 and 2025 the company received 1 grants, compared with 5 in the 2015–2019 window, a -80% shift in five-year velocity. A cooling filing rate may reflect portfolio consolidation, shifting priorities, or reduced R&D throughput. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. Sinclair Pharmaceuticals Ltd's 21.5 average claims per patent reflects complex, broadly scoped inventions that are difficult for competitors to design around, while concentration in 9 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Sinclair Pharmaceuticals Ltd against peers pursuing similar technology classes.

Silverback Therap…

6
Silverlit

6
Simes S p A

6
Sinbon

6
Sinclair Televisi…

6
Sindoh

6
Singapore Dynamic…

6
Singapore Volitio…

6
Sinclair Pharmace… ◀

6

What this shows Sinclair holds 6 patents at rank #42,898, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Sinclair

By rank, the assignees closest to #42,898 in granted patent volume.

Leaders in A61B (Diagnosis)

Other assignees with the most granted patents in Sinclair's primary technology class.

Sinclair's Innovation Score vs. every tracked assignee

Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)

30 Top 66% higher than 34% of 50,000 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2020

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Sinclair Pharmaceuticals Ltd patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	2	33.3%
2017	1	16.7%
2018	2	33.3%
2020	1	16.7%

Which technologies does Sinclair Pharmaceuticals Ltd patent most?

A61B - DIAGNOSIS; SURGERY; IDENTIFICATION 4

A61F - FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRS 4

A61Q - SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS 2

A61K - PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES 2

A01N - PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF ; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES ; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS 1

A61P - SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS 1

Y10T - TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION 1

A61L - METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES 1

A61M - DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY ; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY ; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR 1

Top 9 of 9 technology areas

Patent Moat Analysis

Portfolio Volume Light

Tech Breadth Focused

Claim Depth Complex

Velocity Declining

Where it ranks

Overall rank by patents

#42,898

Across all tracked assignees

Innovation Score

30.2 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

How many patents does Sinclair Pharmaceuticals Ltd hold?

Sinclair Pharmaceuticals Ltd holds 6 US granted patents filed between 2015 and 2020, spanning 9 technology areas.

What is Sinclair Pharmaceuticals Ltd's Innovation Score?

Sinclair Pharmaceuticals Ltd has an Innovation Score of 30.2 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Sinclair Pharmaceuticals Ltd focus on?

Sinclair Pharmaceuticals Ltd's top technology area is A61B (DIAGNOSIS; SURGERY; IDENTIFICATION) with 4 patents. The company has filed patents in 9 CPC subclasses total.

Is Sinclair Pharmaceuticals Ltd's patent filing rate increasing or decreasing?

Sinclair Pharmaceuticals Ltd's recent filing velocity is -80% compared to the prior five-year period. Filing activity has slowed relative to earlier years.

What does claim depth mean for Sinclair Pharmaceuticals Ltd's patents?

Sinclair Pharmaceuticals Ltd's patents average 21.5 claims each. This indicates complex, broadly scoped patents that are harder for competitors to design around.

How is the Sinclair Pharmaceuticals Ltd patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

How to use this portfolio

Sinclair's 6 grants land it in the top 66% by Innovation Score, but volume alone doesn't tell you where the strength sits.

Read that count against the largest US assignees before treating it as dominance - Sinclair ranks #42,898 of 50,000. Top 50 holders
Most of this portfolio concentrates in A61B - see who else leads that technology area. A61B leaders
Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works

Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent Editorial

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled byPlainPatent Editorial, US Patent Intelligence Editorial Team · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.